Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review
- PMID: 19686281
- DOI: 10.1111/j.1469-0691.2009.03019.x
Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review
Abstract
Treatment limitations exist for drug-resistant Acinetobacter baumannii central nervous system (CNS) infection. We conducted a retrospective study and systematic literature review to identify patients with drug-resistant A. baumannii CNS infection who received primary or adjunct intrathecal or intraventricular (IT/IVT) colistin. In a case series of seven Thai patients and 17 patients identified in the literature, clinical and microbiological cure rates with IT/IVT colistin therapy were 83% and 92%, respectively. Three patients (13%) developed chemical ventriculitis and one (4%) experienced treatment-associated seizures. Death was associated with delayed IT/IVT colistin therapy compared to survival (mean time from diagnosis to IT/IVT colistin, 7 vs. 2 days; p 0.01). The only independent predictor of mortality was the severity of illness (APACHE II score > 19, adjusted odds ratio 49.5; 95% CI 1.7-1428.6; p 0.02). This case series suggests that administration of primary or adjunctive IT/IVT colistin therapy was effective for drug-resistant A. baumannii CNS infection.
Similar articles
-
Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature.Int J Infect Dis. 2010 Jul;14(7):e572-9. doi: 10.1016/j.ijid.2009.06.032. Epub 2009 Nov 4. Int J Infect Dis. 2010. PMID: 19892577
-
Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis.J Antimicrob Chemother. 2018 Jan 1;73(1):22-32. doi: 10.1093/jac/dkx368. J Antimicrob Chemother. 2018. PMID: 29069421
-
Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii.Int J Antimicrob Agents. 2018 Apr;51(4):646-650. doi: 10.1016/j.ijantimicag.2017.12.002. Epub 2017 Dec 11. Int J Antimicrob Agents. 2018. PMID: 29241820
-
Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review.J Antimicrob Chemother. 2006 Nov;58(5):1078-81. doi: 10.1093/jac/dkl347. Epub 2006 Aug 17. J Antimicrob Chemother. 2006. PMID: 16916866
-
Effectiveness of combination therapy with intrathecal or intraventricular administration of polymyxin B for hospital-acquired central nervous system infections caused by carbapenem-resistant Acinetobacter baumannii: A retrospective study.Int J Antimicrob Agents. 2024 Dec;64(6):107334. doi: 10.1016/j.ijantimicag.2024.107334. Epub 2024 Sep 21. Int J Antimicrob Agents. 2024. PMID: 39312980
Cited by
-
Comprehensive Therapeutic Approaches to Tuberculous Meningitis: Pharmacokinetics, Combined Dosing, and Advanced Intrathecal Therapies.Pharmaceutics. 2024 Apr 14;16(4):540. doi: 10.3390/pharmaceutics16040540. Pharmaceutics. 2024. PMID: 38675201 Free PMC article. Review.
-
Catheter-Associated Vancomycin-Resistant Enterococcus faecium Ventriculitis and Multidrug-Resistant Acinetobacter baumannii Pneumonia With Subsequent Acinetobacter Ventriculitis: A Case Report.Cureus. 2023 Nov 19;15(11):e49058. doi: 10.7759/cureus.49058. eCollection 2023 Nov. Cureus. 2023. PMID: 38116362 Free PMC article.
-
Successful management of nosocomial ventriculitis and meningitis caused by extensively drug-resistant Acinetobacter baumannii in Austria.Can J Infect Dis Med Microbiol. 2013 Fall;24(3):e88-90. doi: 10.1155/2013/613865. Can J Infect Dis Med Microbiol. 2013. PMID: 24421838 Free PMC article.
-
Clinical Characteristics, Treatment, and Outcomes of Veterans with Cerebrospinal Fluid Culture Positive for Gram-Negative Rod Bacteria: A Retrospective Analysis over 18 Years in 125 Veterans Health Administration Hospitals.Curr Microbiol. 2024 Jan 19;81(2):70. doi: 10.1007/s00284-023-03593-6. Curr Microbiol. 2024. PMID: 38240847
-
Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection.Sci Rep. 2015 Nov 24;5:17091. doi: 10.1038/srep17091. Sci Rep. 2015. PMID: 26597507 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical